# Artelo Biosciences, Inc. (ARTL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ARTL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -13.19M | $ -10.10M | $ 693.0K | $ -1.27M |
| 2024 | $ 0 | $ -10.33M | $ -7.87M | $ 104.0K | $ 2.86M |
| 2023 | $ 0 | $ -10.04M | $ -8.87M | $ 23.0K | $ 11.75M |
| 2022 | $ 0 | $ -11.26M | $ -8.95M | $ 63.0K | $ 19.40M |
| 2021 | $ 0 | $ -10.16M | $ -8.02M | $ 88.0K | $ 27.17M |
| 2020 | $ 0 | $ -6.09M | $ -5.88M | $ 0 | $ 9.05M |
| 2019 | $ 0 | $ -3.77M | $ -6.38M | $ 0 | $ 4.96M |
| 2018 | $ 0 | $ -3.24M | $ -2.43M | $ 0 | $ -475.2K |
| 2017 | $ 0 | $ -676.8K | $ -522.1K | $ 0 | $ 294.0K |
| 2016 | $ 0 | $ -33.0K | $ -5.8K | $ 0 | $ -6.5K |
| 2015 | $ 0 | $ -40.0K | $ -38.3K | $ 0 | $ 15.3K |
| 2014 | $ 0 | $ -24.4K | $ -22.1K | $ 0 | $ 14.7K |
| 2013 | $ 0 | $ -4.7K | $ 0 | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.54 |
| Liabilities / Eq | -3.20 |
| Current Ratio | 0.17 |

## Other views

- [Metrics](https://sponda.capital/en/ARTL.md)
- [Charts](https://sponda.capital/en/ARTL/charts.md)
- [Compare](https://sponda.capital/en/ARTL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.